v3.26.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2024 $ 161,000 $ 323,150,000 $ (303,072,000) $ 20,239,000 $ 12,477,000 $ 32,716,000
Balance, shares at Dec. 31, 2024 8,092,518          
Stock-based payments for professional services 190,000 190,000 190,000
Stock based payments - Impact BioMedical, Inc. 5,000 5,000 5,000
Issuance of common stock, net of expenses - Impact BioMedical, Inc. 1,000 2,082,000 2,083,000 331,000 2,414,000
Issuance of common stock for bonus $ 20,000 850,000 870,000 870,000
Issuance of common stock for bonus, shares 1,000,000            
Net loss (9,184,000) (9,184,000) (903,000) (10,087,000)
Balance at Sep. 30, 2025 $ 182,000 326,277,000 (312,256,000) 14,203,000 11,905,000 26,108,000
Balance, shares at Sep. 30, 2025 9,092,518          
Balance at Dec. 31, 2025 $ 182,000 325,987,000 (327,001,000) (832,000) 9,547,000 8,715,000
Balance, shares at Dec. 31, 2025 9,092,518          
Stock based payments - Impact BioMedical, Inc. 1,282,000 1,282,000 158,000 1,440,000
Net loss (15,046,000) (15,046,000) (1,265,000) (16,311,000)
Issuance of common stock, net of expenses $ 18,000 685,000 703,000 703,000
Issuance of common stock, net of expenses, shares 950,000            
Fair value adjustment related to convertible bond received from related party 6,198,000 6,198,000 6,198,000
Issuance of warrants in connection with convertible promissory note 3,571,000 3,571,000 3,571,000
Balance at Sep. 30, 2026 $ 200,000 $ 337,723,000 $ (342,047,000) $ (4,124,000) $ 8,440,000 $ 4,316,000
Balance, shares at Sep. 30, 2026 10,042,518